Higher IGFBP-2 and/or IGFBP-3 may be associated with increased cancer risk [310], but a recent meta-analysis evidenced that the IGFBP-3 polymorphisms are not associated with colorectal cancer susceptibility [311]. This evidence concerns the gene IGFBP3 and colorectal cancer.